Clark James David 4
4 · CVS HEALTH Corp · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Clark James David
SVP, Cont & Chief Acct Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-05$62.21/sh+7,513$467,384→ 15,907 total - Exercise/Conversion
Stock Option
2025-03-05−7,513→ 0 totalExercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (7,513 underlying) - Sale
Common Stock
2025-03-05$66.35/sh−7,513$498,488→ 8,394 total
Footnotes (1)
- [F1]Options became exercisable in four equal annual installments, commencing 4/1/2019.